Uccelli Licia, Boschi Alessandra, Cittanti Corrado, Martini Petra, Lodi Luca, Zappaterra Elisa, Romani Simona, Zaccaria Samanta, Cecconi Davide, Rambaldi Ilaria, Santi Ivan, Panareo Stefano, Giganti Melchiore, Bartolomei Mirco
Morphology, Surgery and Experimental Medicine Department, University of Ferrara, Ferrara, Italy.
Nuclear Medicine Unit, University Hospital, Ferrara (FE), Italy.
Curr Radiopharm. 2018;11(2):130-137. doi: 10.2174/1874471011666180509101420.
Gallium-68 is a PET isotope available in each nuclear medicine departments, even those not equipped with a cyclotron, since it is easily obtained by eluting compact and transportable generator system. The preparation of Ga-68 DOTA-labeled compounds is performed by remotely controlled automated systems developed in order to ensure production efficiency, reproducibility of the results, fast reaction time, to facilitate the synthesis and minimize the radiation exposure. Many automatic synthesis systems are available on the radiopharmaceutical market, however, they requires some technical adaptations for routine use. We reported the [68Ga]Ga-DOTA-TOC production by automated cassette-based theranostic synthesizer system used in combination with a disposable GMP grade cassette system for cationic purification.
The synthesizer is integrated with the 68Ge/68Ga generator systems and it allows to perform elution, eluate purification and radiolabeling in about 38 minutes. We have performed in 2 year (January 2016 - January 2018) over 100 [68Ga]Ga-DOTA-TOC preparations.
The average synthesis yield of radiopharmaceutical production was 54.4 ± 2.3 % and the radiochemical purity average was found 96.94 ± 0.74 %. Only three [68Ga]Ga-DOTA-TOC preparations have failed.
The methodology and the adopted technical solutions allowed to obtain a high quality radiopharmaceutical product as required by the European Pharmacopoeia.
镓 - 68是一种正电子发射断层显像(PET)同位素,各核医学科室均可获取,即便那些未配备回旋加速器的科室也能得到,因为通过洗脱紧凑且便于运输的发生器系统就能轻松获得镓 - 68。镓 - 68 四氮杂环十二烷四乙酸(DOTA)标记化合物的制备通过远程控制的自动化系统完成,该系统旨在确保生产效率、结果的可重复性、快速反应时间,便于合成并将辐射暴露降至最低。放射性药物市场上有许多自动合成系统,但它们在常规使用时需要一些技术调整。我们报告了使用基于一次性药品生产质量管理规范(GMP)级盒式系统进行阳离子净化的基于盒式的治疗诊断合成器系统自动生产[68Ga]镓 - DOTA - 奥曲肽(TOC)的情况。
该合成器与68锗/68镓发生器系统集成,可在约38分钟内完成洗脱、洗脱液纯化和放射性标记。我们在2年(2016年1月至2018年1月)内进行了100多次[68Ga]镓 - DOTA - TOC的制备。
放射性药物生产的平均合成产率为54.4±2.3%,放射性化学纯度平均为96.94±0.74%。只有三次[68Ga]镓 - DOTA - TOC的制备失败。
所采用的方法和技术解决方案能够按照欧洲药典的要求获得高质量的放射性药物产品。